Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation.

@article{Blijlevens2000ProcalcitoninDN,
  title={Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation.},
  author={Nicole Ma Blijlevens and J. Peter Donnelly and Jacques F Meis and M H De Keizer and Ben E. de Pauw},
  journal={Clinical and diagnostic laboratory immunology},
  year={2000},
  volume={7 6},
  pages={889-92}
}
Procalcitonin (PCT) is an early marker of bacterial infection but little is known about its value in neutropenic allogeneic bone marrow transplant (BMT) recipients. We collected plasma from 12 recipients of T-cell-depleted HLA-matched related BMT recipients who had been treated preemptively with meropenem from the day after BMT for at least 15 days. PCT and C-reactive protein (CRP) concentrations were determined on BMT days 1, 5, 8, 12, and 15, and their relationship to inflammatory events (IE… CONTINUE READING